Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Glaucoma Angle-Closure

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Glaucoma Angle-Closure:

Pubmed Logo
Recurrent angle-closure glaucoma.
PURPOSE: To compare the intraocular pressure (IOP) readings taken by...
13th November, 2009
New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, J Glaucoma. 2009 Sep;18(7):567-70.
DOI Direct Link
Selective laser trabeculoplasty for primary angle closure with persistently elevated intraocular pressure after iridotomy.
PURPOSE: To determine whether selective laser trabeculoplasty (SLT) can...
13th November, 2009
Department of Ophthalmology, Singapore National Eye Center, Tan Tock Seng J Glaucoma. 2009 Sep;18(7):563-6.
DOI Direct Link
Follow-up of primary angle closure suspects after laser peripheral iridotomy using ultrasound biomicroscopy and A-scan biometry for a period of 2 years.
AIM: To determine the morphologic changes in the anterior segment of...
13th November, 2009
Department of Glaucoma, Elite School of Optometry, Medical and Vision J Glaucoma. 2009 Sep;18(7):521-7.
DOI Direct Link
Potential of the pentacam in screening for primary angle closure and primary angle closure suspect.
PURPOSE: To compare the Pentacam to ultrasound biomicroscopy (UBM) or...
13th November, 2009
Department of Ophthalmology, Graduate School of Medicine, The University J Glaucoma. 2009 Sep;18(7):506-12.
DOI Direct Link
Mefenamic acid-induced bilateral transient myopia, secondary angle closure glaucoma and choroidal detachment.
Drug-induced secondary angle closure is quite common and in the majority...
11th November, 2009
Glaucoma Services, Aravind Eye Hospital, Coimbatore-641014, India. Indian J Ophthalmol. 2009 Sep-Oct;57(5):398-400.
DOI Direct Link

View more research publications.

Press Releases About Glaucoma Angle-Closure:

BioPortfolio Logo
Endologix Receives IDE Approval for Fully Percutaneous Approach to EVAR 18th November, 2009 Endologix, Inc.
IRVINE, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received Investigational
deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 17th November, 2009 deCODE genetics
REYKJAVIK, Iceland, Nov. 17 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States
Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product 11th November, 2009 Kensey Nash Corporation
EXTON, Pa., Nov. 11 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range
Reportlinker Adds The Future of the Wound Care Management Market to 2015 10th November, 2009 Reportlinker
NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. The Future of the Wound Care Management Market to 2015 http://www
Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development 26th October, 2009 Reportlinker
-- Prospects for ion channel modulators and commercial successes to date-- Pipeline activities, expert views, and survey results Ion Channel Modulator Pipelines: Targets and Agents in

BioNews Results for Glaucoma Angle-Closure:

RSS Logo
BioPortfolio Logo
ReGAE 8: Is There A Relationship Between Social Deprivation And Acute Primary Angle Closure?
British Journal of Ophthalmology:  Oct 14 2009 11:29PM Matching: glaucoma angle closure

Glaucoma Angle-Closure Patents:

USPTO Logo
US Patent No.Title
7511057 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
5599535 Methods for the cyto-protection of the trabecular meshwork
5674888 Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
6319274 Devices and techniques for light-mediated stimulation of trabecular meshwork in glaucoma therapy
6664287 Antioxidants

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Glaucoma Angle-Closure scientists - we have details of around 142 individuals working on Glaucoma Angle-Closure .


This page has been viewed 276 times
Recent Search Terms used to find this page: angle closure glaucoma vidioes | angle closure glaucoma vidioes | angle closure glaucoma vidioes | angle closure glaucoma vidioes | ppar,glaucoma | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Glaucoma Angle-Closure across BioPortfolio, or for Glaucoma Angle-Closure Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.